Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) Chief Medical Officer Dr. Rakesh Jetly tells Proactive it has signed a letter of intent with Calgary-based The Newly Institute Inc to provide psychedelic-assisted psychotherapy to patients. The two companies will create a package of resources for patients and medical professionals to be accepted into Health Canada’s Special Access Program.
Mydecine to partner with The Newly Institute to offer psychedelic-assisted psychotherapy
